Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Retained Earnings (2016 - 2017)

Bone Biologics (BBLG) has disclosed Retained Earnings for 2 consecutive years, with $56.4 million as the latest value for Q3 2017.

  • On a quarterly basis, Retained Earnings rose 18.93% to $56.4 million in Q3 2017 year-over-year; TTM through Sep 2017 was $56.4 million, a 18.93% increase, with the full-year FY2016 number at -$52.1 million, changed N/A from a year prior.
  • Retained Earnings was $56.4 million for Q3 2017 at Bone Biologics, up from $54.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $56.4 million in Q3 2017 to a low of -$52.1 million in Q4 2016.